Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer’s disease

We systematically prioritized AD candidate causal genes based on cell type-level and bulk level molecular evidence. The integrative approach enhances our understanding of molecular mechanisms of AD-related genetic variants and facilitates interpretation of AD GWAS results.